Cargando…

The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy

Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced cardiomyopathy. We herein present a 54-year-old woman with recurrent metastatic breast cancer who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiga, Tsuyoshi, Im, Jihaeng, Kikuchi, Noriko, Arakawa, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479229/ https://www.ncbi.nlm.nih.gov/pubmed/33746165 http://dx.doi.org/10.2169/internalmedicine.6787-20

Ejemplares similares

Development of anthracycline-induced dilated cardiomyopathy due to mutation on LMNA gene in a breast cancer patient: a case report
por: Kuruc, Jock Chichaco, et al.
Publicado: (2019)

Pathological changes of the myocardium in reworsening of anthracycline-induced cardiomyopathy after explant of a left ventricular assist device
por: Hiraiwa, Hiroaki, et al.
Publicado: (2020)

Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy
por: Kikuchi, Noriko, et al.
Publicado: (2020)

Comparison of creatinine‐based equations for estimating renal function for digoxin dose adjustment in patients with atrial fibrillation and heart failure
por: Sakai, Masahiro, et al.
Publicado: (2023)

Therapeutic drug monitoring on the use of transplacental digoxin in fetal tachyarrhythmia: a case report
por: Jeong, Sae Im, et al.
Publicado: (2022)

Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines
por: Tagawa, Michihito, et al.
Publicado: (2021)

A case series about the favorable effects of sacubitril/valsartan on anthracycline cardiomyopathy
por: De Vecchis, Renato, et al.
Publicado: (2020)

Colored floaters as a manifestation of digoxin toxicity
por: Shi, Lynn, et al.
Publicado: (2018)

Inadvertent Intrathecal Administration of Digoxin, with Review of the Literature
por: Tabaac, Burton J., et al.
Publicado: (2023)

Disclosing an In-Frame Deletion of the Titin Gene as the Possible Predisposing Factor of Anthracycline-Induced Cardiomyopathy: A Case Report
por: Chang, Yu-Wei, et al.
Publicado: (2022)

Weekly paclitaxel in escalating doses in a patient with anthracycline-resistant, triple-negative, metastatic breast cancer with severe liver dysfunction
por: Gupta, Ajay
Publicado: (2012)

Inappropriate use of digoxin in patients presenting with digoxin toxicity
por: Tatlisu, Mustafa Adem, et al.
Publicado: (2015)

Spectrum of digoxin-induced ocular toxicity: a case report and literature review
por: Renard, Delphine, et al.
Publicado: (2015)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2023)

Severe suicidal digoxin and propranolol toxicity with insulin overdose
por: Garg, Ashish, et al.
Publicado: (2014)

Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data
por: Hirai, Toshinori, et al.
Publicado: (2022)

Combination Chemotherapy of Mitomycin C and Methotrexate Was Effective on Metastatic Breast Cancer Resistant to Eribulin, Vinorelbine, and Bevacizumab after Anthracycline, Taxane, and Capecitabine
por: Tanabe, Masahiko
Publicado: (2016)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)

An overlap of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Kataoka, Shohei, et al.
Publicado: (2016)

Ouabain and Digoxin Activate the Proteasome and the Degradation of the ERα in Cells Modeling Primary and Metastatic Breast Cancer
por: Busonero, Claudia, et al.
Publicado: (2020)

Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin
por: Shee, Kevin, et al.
Publicado: (2016)

Rare Manifestation of Digoxin Toxicity: Right Bundle Branch Block
por: Gill, Dalvir, et al.
Publicado: (2016)

Anthracycline-induced cardiomyopathy: Is there a new light at the end of the tunnel?
por: Fradley, Michael G., et al.
Publicado: (2021)

Use of digoxin-specific antibody fragments (Fab) in the management of digoxin poisoning.
por: Brown, J. H., et al.
Publicado: (1986)

The comparison of anthracycline-based and non-anthracycline-based regimens in adjuvant chemotherapy of HER2-positive non-metastatic breast cancers
por: Najafi, Safa, et al.
Publicado: (2018)

Breast cancer in women using digoxin: tumor characteristics and relapse risk
por: Biggar, Robert J, et al.
Publicado: (2013)

CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy
por: Kanelidis, Anthony J., et al.
Publicado: (2020)

Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane
por: Ahn, Jin-Hee, et al.
Publicado: (2004)

Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane
por: Saji, Shigehira
Publicado: (2013)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
por: Distefano, Giuseppe
Publicado: (2009)

Severe suicidal digoxin toxicity managed with resin hemoperfusion: A case report
por: Juneja, Deven, et al.
Publicado: (2012)

Accidental Intrathecal Administration of Digoxin in an Elderly Male with End-Stage Renal Disease
por: Martin, Claudia, et al.
Publicado: (2017)

Drug-Induced Interstitial Lung Disease after Anthracycline-Combined Chemotherapy for Breast Cancer: A Case Report and Literature Review
por: Hoshina, Hideko, et al.
Publicado: (2021)

Hydronephrosis Caused by Metastatic Breast Cancer
por: Sugimoto, Hitoshi, et al.
Publicado: (2021)

Metastatic colonic and gastric polyps from breast cancer resembling hyperplastic polyps
por: Horimoto, Yoshiya, et al.
Publicado: (2018)

Anthracycline-induced cardiotoxicity: A case report and review of literature
por: Chong, Esther G, et al.
Publicado: (2021)

Erratum to: Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane
por: Saji, Shigehira
Publicado: (2013)

Potential role of pemetrexed in metastatic breast cancer patients pre-treated with anthracycline or taxane
por: Zhou, Li-Yan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c16phdperovkm9eopg2gc6tbne